| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
DMH-1 | 1206711-16-1 | sc-361171 sc-361171B sc-361171A sc-361171C | 10 mg 25 mg 50 mg 100 mg | $209.00 $312.00 $620.00 $1026.00 | 2 | |
DMH1 selectively inhibits BMP type I receptors ALK2, ALK3, and ALK6, subsequently suppressing BMP signaling. Although not directly targeting FAM83G, it may indirectly influence its associated activities. | ||||||
4-(6-(4-(Piperazin-1-yl)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)quinoline | 1062368-24-4 | sc-476297 | 5 mg | $240.00 | ||
LDN-193189 selectively inhibits ALK2 and ALK3 receptors. By modulating BMP signaling, it could indirectly impact the functional role of FAM83G in this pathway. | ||||||
LDN-214117 | 1627503-67-6 | sc-507451 | 5 mg | $165.00 | ||
LDN-214117 is another BMP inhibitor targeting ALK2. Its effects on the BMP pathway might indirectly influence FAM83G functions. | ||||||
5-[6-[4-(1-Piperazinyl)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]quinoline | 1432597-26-6 | sc-476318 | 5 mg | $380.00 | ||
This molecule selectively inhibits BMP receptors ALK1, ALK2, and ALK3. Indirect effects on FAM83G are theoretically possible given its involvement in the BMP pathway. | ||||||
K02288 | 1431985-92-0 | sc-488981 | 5 mg | $330.00 | ||
K02288 is a selective ALK1 and ALK2 inhibitor. By inhibiting these BMP receptors, it may have downstream impacts on associated proteins like FAM83G. | ||||||
EW-7197 | 1352608-82-2 | sc-507465 | 5 mg | $345.00 | ||
While primarily known as a TGF-β type I receptor inhibitor, its effects on BMP signaling can indirectly influence proteins involved in the same or related pathways, like FAM83G. | ||||||
LDN 193719 | 1062368-49-3 | sc-489383 | 10 mg | $189.00 | ||
LDN 193719 selectively inhibits BMP receptors ALK1 and ALK2. Its actions might indirectly modify FAM83G's associated activities within the BMP pathway. | ||||||
A 83-01 | 909910-43-6 | sc-203791 sc-203791A | 10 mg 50 mg | $198.00 $650.00 | 16 | |
A83-01 inhibits ALK5, ALK4, and ALK7. Though primarily a TGF-β pathway inhibitor, cross-talk between pathways could lead to indirect effects on FAM83G. | ||||||
SB-505124 | 694433-59-5 | sc-362794 sc-362794A | 10 mg 50 mg | $321.00 $1350.00 | 2 | |
This inhibitor selectively targets ALK4, ALK5, and ALK7. As with other TGF-β inhibitors, indirect effects on FAM83G via pathway cross-talk are theoretically possible. | ||||||